EUVIMEDEUVIMED entdecken
Crossref

Historical, Pharmacological, Clinical, and Regulatory Evolution of Hirudotherapy: An Evidence-Informed Traditional Narrative Review

Yücel Kati

Journal of Immunology and Clinical Microbiology · 18.08.2026 · 11 (2) · 106-116

DOI: 10.58854/jicm.1954558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology and Clinical Microbiology, online erschienen am 18.08.2026. Verfasst von Yücel Kati. Die Arbeit nennt 43 Literaturangaben. Gefördert von: This study received no financial support from any institution, organization, or funding body..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This traditional narrative review aimed to synthesize the historical development, pharmacological basis, contemporary clinical indications, safety concerns, contraindications, and regulatory framework of hirudotherapy.

Methods

Literature was identified through targeted searches of PubMed, Scopus, CrossRef, Google Scholar, publisher databases, and official regulatory sources. The search focused on medicinal leech therapy, Hirudo medicinalis, hirudin, venous congestion, reconstructive surgery, microsurgery, knee osteoarthritis, contraindications, Aeromonas infection, and traditional and complementary medicine. Peer-reviewed reviews, systematic reviews, meta-analyses, randomized controlled trials, pharmacological studies, reconstructive surgery literature, historical sources, and official regulatory documents were prioritized.

Results

Hirudotherapy has evolved from a traditional bloodletting practice into a mechanism-informed intervention with limited but clinically relevant modern indications. The strongest evidence-supported indication is the management of venous congestion after reconstructive microsurgery, replantation, and flap procedures. Symptomatic knee osteoarthritis appears promising but remains limited by methodological constraints and safety concerns. In contrast, broad claims involving cosmetic, metabolic, neurologic, reproductive, oncologic, or systemic diseases are insufficiently supported. Major risks include prolonged bleeding, anemia, allergic reactions, wound complications, and Aeromonas-related infection.

Conclusion

Modern hirudotherapy should not be justified by historical continuity alone. It should be applied only within clearly defined indications, under medical supervision, with appropriate patient selection, infection-control measures, safety monitoring, and regulatory compliance.

Förderung

  • This study received no financial support from any institution, organization, or funding body.

Zitieren

APA

Kati, Y. (2026). Historical, Pharmacological, Clinical, and Regulatory Evolution of Hirudotherapy: An Evidence-Informed Traditional Narrative Review. Journal of Immunology and Clinical Microbiology, 11(2), 106-116. https://doi.org/10.58854/jicm.1954558

Vancouver

Kati Y. Historical, Pharmacological, Clinical, and Regulatory Evolution of Hirudotherapy: An Evidence-Informed Traditional Narrative Review. Journal of Immunology and Clinical Microbiology. 2026;11(2):106-116. doi:10.58854/jicm.1954558

BibTeX
@article{Kati2026,
  author = {Kati, Yücel},
  title = {Historical, Pharmacological, Clinical, and Regulatory Evolution of Hirudotherapy: An Evidence-Informed Traditional Narrative Review},
  journal = {Journal of Immunology and Clinical Microbiology},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {106--116},
  doi = {10.58854/jicm.1954558}
}
Kostenlos starten →